Sickle cell disease (SCD) is a target condition of the national newborn screening (NBS) programs in only five countries (France, Greece, The Netherlands, Spain and UK). However, the importance of SCD screening is increasingly acknowledged as a global challenge all over Europe and various regional programs as well as pilot studies have been initiated during last years. This Conference aims to evaluate the current situation of SCD NBS in Europe and general and discuss the pertinence of the various screening strategies. For more information please go to Pan-European Consensus Conference on Newborn Screening for Haemoglobinopathies website
Organizing committee: Elena Cela, Madrid Raffaella Colombatti, Padua Jacques Elion, Paris Stephan Lobitz, Berlin
The objective of the course is to give opportunity to the attendees to have close contact and lively interaction with the teachers and the group in a nice setting. All slides will be available onsite. The speakers are chosen not only for their expertise in their subject but also for their teaching skills and willingness to discuss the field of transplant in both formal and informal settings. The course is suitable for physicians at all stages of their career and is particularly useful for those in training, for those who wish to develop their current practice to a more challenging type of transplant and also as an update for established transplanters. The program will include: • Plenary sessions • Clinical cases • Poster presentation • Breakfast meet the expert sessions • Meet the expert dinner
European School of Hematology and European Society for Blood and Marrow Transplantation.
The EHA Annual Congress provides a forum for presenting original unpublished data and sharing ideas for hematological innovation as well as disseminating evidence-based knowledge of primary clinical relevance. Hematologists and affiliated professionals attending the EHA Congress will be able to: Enhance their knowledge of evidence-based approaches on diagnosis and treatment for hematologic diseases. Access the latest results on clinical and translational research in hematologic disorders. Be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties. Communicate, collaborate and network with representatives of a large international audience – medical professionals, national hematology societies, patient groups, medical industry and the media.
European Hematology Association (EHA)
The International Summer school intend i) to promote the establishment of Findable, Accessible, Interoperable, Reusable (FAIR) registries in compliance with IRDiRC and EU Recommendations and ii) to support cooperation among different registry stakeholders and coordination with registries that are developed within European Reference Networks and National Plans in the EU.
Istituto Superiore di Sanità
As in previous workshops, proposed abstracts will be subjected to approval by the scientific committee and amended where necessary to improve English expression. Invited lectures and accepted communications/posters will be considered for publication as full papers as a topical focus in an issue of Accreditation and Quality Assurance (Springer Verlag), subject to peer-review.
EURACHEM in cooperation with CITAC and EQALM
The next EQALM symposium and General Assembly will be held in Dublin, Ireland on 19-20 October, 2017. Futher details will be published when available.
European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM)
Thalassaemia International Federation (TIF)
Save the date for the world’s most comprehensive hematology event of the year, the 59th ASH Annual Meeting and Exposition, in vibrant, fresh, and creative Atlanta. The meeting will provide an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Network with top minds in the field as well as a global community of more than 25,000 hematology professionals from every subspecialty.
American Society of Hematology (ASH)